Sam has represented clients in a wide array of transactions, business ventures and general corporate matters. He has extensive experience representing private equity funds in leveraged buyouts of public and private companies, growth equity and venture capital investments, divestitures and recapitalizations. He also represents publicly traded and privately held companies in connection with a variety of corporate matters, including strategic mergers and other acquisitions, divestitures, joint ventures, financings, restructurings, recapitalizations and general corporate matters.

In addition, Sam advises boards of directors of publicly traded and privately held companies with respect to complex transactions, corporate governance and other material corporate matters. He also represents publicly held companies, venture capital funds and emerging companies in early and later stage venture investments.

Show Less

• Represented Great Point Partners in connection with multiple acquisitions and investments, including the following: American Surgical Holdings, Inc. (OTCBB: ASRG); Aris Teleradiology, Inc.; Connecture, Inc.; iVantage Health Analytics, Inc.; the Millennium Physical Therapy entities; MZI Healthcare, Inc.; Optimal Radiology, Inc.; Orange Health Solutions, Inc.; the Professional Orthopedic and Sports Physical Therapy entities; Specialized Radiology Services, Inc.; Surgbill, Inc.; and United Surgical Assistants, Inc.
• Represented multiple other private equity funds in acquisitions or divestitures, including Aurora Resurgence, Bayside Opportunity Fund, Glencoe Capital, Fireman Capital and Riverside Partners
• Represented Commercial Markets Holdco, Inc., in connection with the sale of its subsidiary, Diversey Holdings, Inc., to Sealed Air Corporation (NYSE: SEE)
• Represented The Genlyte Group Incorporated (NASDAQ: GLYT) in connection with its sale to a wholly-owned subsidiary of Royal Philips Electronics N.V. (NYSE: PHG)

Show Less